Long-term follow-up of Cladribine, high-dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review.
European journal of haematology
View this publicationEuropean journal of haematology
View this publicationCell reports
View this publicationOncoimmunology
View this publicationScientific reports
View this publicationJACC. Cardiovascular interventions
View this publicationJournal of the American Academy of Dermatology
View this publicationNature reviews. Neurology
View this publicationInternational journal of cardiology. Heart & vasculature
View this publicationEuropean journal of immunology
View this publicationTrends in immunology
View this publication